TRIB3 has been proposed as a key target to treat obesity-related diseases, as many studies have shown that its overexpression prevents the detrimental effects of diet-induced obesity by modulating lipid metabolism (9), promoting insulin resistance (10–12) and inhibiting adipocyte differentiation (13–15). This evidence concerns the gene TRIB3 and Insulin resistance.